Text size Sanofi is limiting its focus on drug development, stopping its diabetes and cardiovascular research. Joel Saget / AFP via Getty Images French pharmaceutical giant Sanofi is digging into the cash it raised earlier this year with the sale of its $ 11.7 billion stake in Regeneron Pharmaceuticals, the …
Read More »
Sanofi agrees to take over US biotech company Principia Biopharma Inc. for about $ 3.4 billion as the French drugmaker turns to innovative therapies to stimulate growth under new Chief Executive Officer Paul Hudson. The all-cash deal will see Sanofi take full control of the company, which focuses on treatments …
Read More »
Text size It is the busiest week of the second quarter earnings season, with 171 S&P 500 companies slated to report. Things start slowly on Monday, before 3M, Advanced Micro Devices, eBay, McDonald’s, Pfizer, Starbucks and Visa reported on Tuesday. On Wednesday, Boeing, Facebook, General Electric, PayPal Holdings, Qualcomm and …
Read More »
Medicago Inc. has been using plants to develop potential vaccines for more than two decades. A new partnership with GlaxoSmithKline Plc. Testing its unproven technology against the new coronavirus is bringing Canadian biotechnology to the limelight. The Quebec City-based company administered the first humans with its experimental Covid-19 vaccine on …
Read More »
In the early days of the COVID-19 pandemic, Sanofi and Regeneron launched an ambitious plan to test rheumatoid arthritis with Kevzara in desperately ill patients. But after the first warning signs, a phase 3 failure has forced drug makers to make their judgment in the United States. Sanofi and Regeneron …
Read More »